|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||36.59 - 37.28|
|52-week range||20.81 - 38.04|
|PE ratio (TTM)||32.96|
|Earnings date||6 Nov 2017 - 10 Nov 2017|
|Forward dividend & yield||N/A (N/A)|
|1y target est||34.83|
Globus Medical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Globus Medical (GMED) saw its shares rise nearly 8% on the day after the company reported year-over-year growth in third-quarter earnings and revenues.
The musculoskeletal-implant maker eyes its new Excelsius GPS robotic surgical system for future growth.
On a per-share basis, the Audubon, Pennsylvania-based company said it had profit of 26 cents. Earnings, adjusted for one-time gains and costs, came to 30 cents per share. The results met Wall Street expectations. ...